30 results
8-K
EX-2.1
KNTE
Kinnate Biopharma Inc
1 Mar 24
Entry into a Material Definitive Agreement
8:50am
, manufacturing, marketing, distributing and selling, as the case may be, products for use in healthcare, focused on precision oncology for cancer patients
S-3ASR
EX-1.2
g407jt fhk
3 Jan 22
Automatic shelf registration
8:51am
8-K
pbsf2a a5mvzc
7 Jun 21
Experienced leaders bring substantial clinical research, regulatory, and operational expertise in the biopharmaceutical industry to the Kinnate team
8:07am
8-K
EX-99.1
dl2 qy26s1ipto1x3
7 Jun 21
Experienced leaders bring substantial clinical research, regulatory, and operational expertise in the biopharmaceutical industry to the Kinnate team
8:07am
10-Q
o94u3 9cdlag3j
17 May 21
Quarterly report
4:26pm
8-K
EX-99.1
qk5wg1cei
13 May 21
Kinnate Biopharma Inc. Closes $35 Million Series A Financing
4:18pm
DEF 14A
jbglyy
30 Apr 21
Definitive proxy
9:13am
10-K
77irp5u
29 Mar 21
Annual report
4:26pm
424B4
d71p8lf1komqdtv1n
3 Dec 20
Prospectus supplement with pricing info
4:48pm